tiprankstipranks
Progyny sees FY23  adjusted EBITDA $166M-$174M
The Fly

Progyny sees FY23 adjusted EBITDA $166M-$174M

Net income is projected to be $27.0 million to $32.7 million, or $0.26 to $0.32 per diluted share, on the basis of approximately 103 million assumed weighted-average fully diluted-shares outstanding

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on PGNY:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles